Moneycontrol PRO
LAMF
LAMF

Ayushman Kumar

Principal Correspondent, Editorial And Content, Moneycontrol

ICMR releases guidelines for drone usage in healthcare, to pilot blood bag delivery

BUSINESS

ICMR releases guidelines for drone usage in healthcare, to pilot blood bag delivery

23,000 Indian medical students from Chinese varsities at govt mercy for two years now

TRENDS

23,000 Indian medical students from Chinese varsities at govt mercy for two years now

Planning 10 percent expansion of field force in FY23: C.S. Muralidharan, Sun Pharma

TRENDS

Planning 10 percent expansion of field force in FY23: C.S. Muralidharan, Sun Pharma

BDR Pharma partners with Varenyam Healthcare to launch Sugmadex

BUSINESS

BDR Pharma partners with Varenyam Healthcare to launch Sugmadex

Explained: How are COVID-19 vaccines destroyed?

TRENDS

Explained: How are COVID-19 vaccines destroyed?

Bring a law to check violence: Doctors on NMC’s proposal for refusing treatment to violent patients, relatives

INDIA

Bring a law to check violence: Doctors on NMC’s proposal for refusing treatment to violent patients, relatives

Pharma industry faces inflation-induced slowdown: Alembic Pharmaceutical CFO

BUSINESS

Pharma industry faces inflation-induced slowdown: Alembic Pharmaceutical CFO

Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of synthetic jaw-bone graft

INDIA

Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of synthetic jaw-bone graft

Government’s crowdfunding plan for treating patients with rare diseases yet to take off

INDIA

Government’s crowdfunding plan for treating patients with rare diseases yet to take off

Israel's Watergen, SMV Jaipuria Group partner to manufacture air-to-water products in India

TRENDS

Israel's Watergen, SMV Jaipuria Group partner to manufacture air-to-water products in India

Affordable healthcare for all to soon be a reality in India: Raajiv Singhal of Marengo Asia

TRENDS

Affordable healthcare for all to soon be a reality in India: Raajiv Singhal of Marengo Asia

Glenmark launches Whatsapp chatbot for patients with fungal infections

HEALTH-AND-FITNESS

Glenmark launches Whatsapp chatbot for patients with fungal infections

Akums Drugs gets India licence to make lipid-lowering bempedoic acid for heart conditions

TRENDS

Akums Drugs gets India licence to make lipid-lowering bempedoic acid for heart conditions

Smart insulin is the future: Vikrant Shrotriya of Novo Nordisk

INDIA

Smart insulin is the future: Vikrant Shrotriya of Novo Nordisk

Dr Reddy’s to reduce prices of Sputnik booster doses

INDIA

Dr Reddy’s to reduce prices of Sputnik booster doses

Going under knife to look good: Make-shift cosmetic clinics thrive in the absence of regulations

TRENDS

Going under knife to look good: Make-shift cosmetic clinics thrive in the absence of regulations

Mankind Pharma launches Docflix, an OTT platform for doctors

TRENDS

Mankind Pharma launches Docflix, an OTT platform for doctors

Content creation, no more a side hustle for doctors? 

TRENDS

Content creation, no more a side hustle for doctors? 

As Lancet flags long COVID concerns, experts in India call for more data and research

TRENDS

As Lancet flags long COVID concerns, experts in India call for more data and research

Zydus launches Bemdac for treatment of uncontrolled LDL-cholesterol in India

TRENDS

Zydus launches Bemdac for treatment of uncontrolled LDL-cholesterol in India

One in four Indian adults is hypertensive, experts blame sedentary lifestyle 

TRENDS

One in four Indian adults is hypertensive, experts blame sedentary lifestyle 

Bharat Biotech partners with CEPI to develop ‘variant-proof’ COVID-19 vaccine

TRENDS

Bharat Biotech partners with CEPI to develop ‘variant-proof’ COVID-19 vaccine

Centre to launch a national public health observatory for integration of government schemes

TRENDS

Centre to launch a national public health observatory for integration of government schemes

Pfizer opens $20-million global drug development centre at IIT-Madras

INDIA

Pfizer opens $20-million global drug development centre at IIT-Madras

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347